Hengrui Medicine (600276.SH): The application for listing permit of SHR7280 tablets has been accepted.

Zhtng Cijng APP News, Hengrui Medicine (600276.SH) announced that the company recently received an "Acceptance Notice" issued by the National Medical Products Administration (referred to as the "NMPA"), and the company's SHR7280 tablet drug market approval application has been accepted by the NMPA.